SGRO

670

+1.03%↑

IWG

178.4

-0.06%↓

SVS

840

+0.24%↑

SNR

287.5

-0.17%↓

SGRO

670

+1.03%↑

IWG

178.4

-0.06%↓

SVS

840

+0.24%↑

SNR

287.5

-0.17%↓

SGRO

670

+1.03%↑

IWG

178.4

-0.06%↓

SVS

840

+0.24%↑

SNR

287.5

-0.17%↓

SGRO

670

+1.03%↑

IWG

178.4

-0.06%↓

SVS

840

+0.24%↑

SNR

287.5

-0.17%↓

SGRO

670

+1.03%↑

IWG

178.4

-0.06%↓

SVS

840

+0.24%↑

SNR

287.5

-0.17%↓

Search

RIT Capital Partners PLC-Fund

Suletud

SektorKinnisvara

2,110 -0.24

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

2110

Max

2115

Põhinäitajad

By Trading Economics

Sissetulek

251M

355M

Müük

-124M

21M

P/E

Sektori keskmine

11.177

57.373

Aktsiakasum

0.74

Dividenditootlus

2.1

Kasumimarginaal

1,724.757

Töötajad

61

EBITDA

243M

370M

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

2.10%

6.91%

Järgmine dividendimakse kuupäev

24. apr 2026

Turustatistika

By TradingEconomics

Turukapital

-95M

2.9B

Eelmine avamishind

2110.24

Eelmine sulgemishind

2110

Uudiste sentiment

By Acuity

50%

50%

61 / 168 Pingereas Real estate

RIT Capital Partners PLC-Fund Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

6. apr 2026, 23:17 UTC

Tulu

Samsung Forecasts Record First-Quarter Operating Profit

6. apr 2026, 23:00 UTC

Kuumad aktsiad

Stocks to Watch: Health Insurers, Mawson, Owlet

6. apr 2026, 22:13 UTC

Suurimad hinnamuutused turgudel

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6. apr 2026, 21:46 UTC

Omandamised, ülevõtmised, äriostud

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6. apr 2026, 17:09 UTC

Suurimad hinnamuutused turgudel

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6. apr 2026, 16:56 UTC

Uudisväärsed sündmused

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6. apr 2026, 14:47 UTC

Suurimad hinnamuutused turgudel

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7. apr 2026, 00:00 UTC

Uudisväärsed sündmused

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6. apr 2026, 23:58 UTC

Market Talk
Uudisväärsed sündmused

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6. apr 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6. apr 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6. apr 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6. apr 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6. apr 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6. apr 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6. apr 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6. apr 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6. apr 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6. apr 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6. apr 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6. apr 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6. apr 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6. apr 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6. apr 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6. apr 2026, 18:36 UTC

Omandamised, ülevõtmised, äriostud

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6. apr 2026, 17:59 UTC

Market Talk
Uudisväärsed sündmused

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6. apr 2026, 17:13 UTC

Omandamised, ülevõtmised, äriostud

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6. apr 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6. apr 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6. apr 2026, 14:59 UTC

Tulu

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Võrdlus sarnastega

Hinnamuutus

RIT Capital Partners PLC-Fund Prognoos

Sentiment

By Acuity

61 / 168 Pingereas Kinnisvara

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest RIT Capital Partners PLC-Fund

RIT Capital Partners Plc is a self-managed investment trust. The firm invests in the public equity and currency markets across the globe. It also invests in private investments and equity funds. The firm benchmarks the performance of its portfolio against the RPI plus 3% and MSCI All Country World Index (50% Sterling). It employs a top-down approach to make its investments. The firm makes its investments in companies operating across diversified sectors. RIT Capital Partners plc was founded on August 1, 1988 and is based in London, United Kingdom.
help-icon Live chat